A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year


Published On: June 17th, 2010

Also: an econ 101 lesson for Medicare; FDA delays consideration of Merck’s Gardasil for older women; more funding for alternatives to driving.

The rest is here: 
A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year



Loading...


Comments are closed.